Asahi Kasei Bioprocess America
Biotechnology, 1855 Elmdale Ave, Glenview, Illinois, 60026, United States, 51-200 Employees
Phone Number: 18*********
Who is ASAHI KASEI BIOPROCESS AMERICA
As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably...
Read More
-
Headquarters: 1855 Elmdale Ave, Glenview, Illinois, 60026, United States
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ASAHI KASEI BIOPROCESS AMERICA
Asahi Kasei Bioprocess America Org Chart and Mapping
Email
Phone
Similar Companies to Asahi Kasei Bioprocess America
Asahi Kasei
-
10001+
-
$ 50 Million to 100 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Asahi Kasei Bioprocess America
Answer: Asahi Kasei Bioprocess America's headquarters are located at 1855 Elmdale Ave, Glenview, Illinois, 60026, United States
Answer: Asahi Kasei Bioprocess America's phone number is 18*********
Answer: Asahi Kasei Bioprocess America's official website is https://ak-bio.com
Answer: Asahi Kasei Bioprocess America's revenue is $10 Million to $25 Million
Answer: Asahi Kasei Bioprocess America's SIC: 2834
Answer: Asahi Kasei Bioprocess America's NAICS: 325412
Answer: Asahi Kasei Bioprocess America has 51-200 employees
Answer: Asahi Kasei Bioprocess America is in Biotechnology
Answer: Asahi Kasei Bioprocess America top competitors include: Asahi Kasei
Answer: Asahi Kasei Bioprocess America contact info: Phone number: 18********* Website: https://ak-bio.com
Answer: As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by PlanovaTM virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, PlanovaTM filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers with products, services and expertise to achieve assurance that is beyond expectation. As part of our dedication to solving therapeutic product safety, efficiency and purity challenges, we also manufacture a comprehensive suite of downstream equipment. With technology platforms for virus filtration, chromatography, inline buffer formulation and oligonucleotide synthesis, our bioprocessing systems, columns and automation solutions advance GMP manufacturing of critical drug substances around the world. Our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month